Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

NeuroPace (NPCE) EBT (2020 - 2025)

NeuroPace (NPCE) has 6 years of EBT data on record, last reported at -$2.7 million in Q4 2025.

  • For Q4 2025, EBT rose 47.15% year-over-year to -$2.7 million; the TTM value through Dec 2025 reached -$21.0 million, up 23.56%, while the annual FY2025 figure was -$21.0 million, 23.56% up from the prior year.
  • EBT reached -$2.7 million in Q4 2025 per NPCE's latest filing, up from -$3.6 million in the prior quarter.
  • Across five years, EBT topped out at -$2.7 million in Q4 2025 and bottomed at -$12.6 million in Q2 2022.
  • Average EBT over 5 years is -$7.9 million, with a median of -$7.8 million recorded in 2021.
  • Peak YoY movement for EBT: crashed 580.36% in 2021, then skyrocketed 47.15% in 2025.
  • A 5-year view of EBT shows it stood at -$10.7 million in 2021, then decreased by 2.89% to -$11.0 million in 2022, then soared by 41.23% to -$6.5 million in 2023, then rose by 20.12% to -$5.2 million in 2024, then surged by 47.15% to -$2.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBT were -$2.7 million in Q4 2025, -$3.6 million in Q3 2025, and -$8.2 million in Q2 2025.